⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL18507656 | 0.97 | — | — | |
| Nitric Acid SCHEMBL18507668 | 0.93 | CA5A (0.36) | — | |
| SCHEMBL9921591 | 0.69 | CCR5 (0.32) | — | |
| SCHEMBL10793901 | 0.65 | — | — | |
| SCHEMBL28394988 | 0.64 | ALDH1A1 (0.35) | — | |
| SCHEMBL8409243 | 0.64 | — | — | |
| SCHEMBL28392434 | 0.64 | MEN1 (0.33) | — | |
| SCHEMBL11804153 | 0.59 | — | — | |
| SCHEMBL9323765 | 0.59 | GSR (0.36) | — | |
| SCHEMBL700571 | 0.57 | ALDH1A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161548-A1 | MEDICATION INFUSION DEVICES, SYSTEMS, AND METHODS | EPICENTRX, INC. (US) | 2025-05-22 | — | — | US | claimed |
| US-20250099666-A1 | MEDICATION INFUSION DEVICES, SYSTEMS, AND METHODS | EPICENTRX, INC. (US) | 2025-03-27 | — | — | US | claimed |
| US-12109348-B2 | Medication infusion devices, systems, and methods | EPICENTRX, INC. (US) | 2024-10-08 | — | — | US | claimed |
| US-12048793-B2 | Medication infusion devices, systems, and methods | EPICENTRX, INC. (US) | 2024-07-30 | — | — | US | claimed |
| CN-111432858-B | Drug infusion device, system and method | 埃皮森特RX股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| US-20230391868-A1 | COMPOSITIONS FOR AND METHODS OF TREATING CANCER | THE GEORGE WASHINGTON UNIVERSITY | 2023-12-07 | — | — | US | claimed |
| CN-115243741-A | Drug infusion device, system and method | 埃皮辛特瑞柯斯公司 | 2022-10-25 | — | — | CN | claimed |
| EP-4072617-A1 | MEDICATION INFUSION DEVICES, SYSTEMS, AND METHODS | EpicentRx, Inc. (US) | 2022-10-19 | — | — | EP | claimed |
| WO-2022109227-A1 | COMBINED CANCER THERAPY OF B7-H3 AND CD47 IMMUNE CHECKPOINT INHBITIOR AND METHODS OF USE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2022-05-27 | — | — | WO | claimed |
| US-20210244870-A1 | MEDICATION INFUSION DEVICES, SYSTEMS, AND METHODS | EPICENTRX, INC. | 2021-08-12 | — | — | US | claimed |
| WO-2021119433-A1 | MEDICATION INFUSION DEVICES, SYSTEMS, AND METHODS | EPICENTRX, INC. (US) | 2021-06-17 | — | — | WO | claimed |
| US-20210178050-A1 | MEDICATION INFUSION DEVICES, SYSTEMS, AND METHODS | EPICENTRX, INC. | 2021-06-17 | — | — | US | claimed |
| EP-3801678-A1 | MEDICATION INFUSION DEVICES, SYSTEMS, AND METHODS | EpicentRx, Inc. (US) | 2021-04-14 | — | — | EP | claimed |
| CN-111432858-A | Drug infusion device, system and method | 埃皮森特RX股份有限公司 | 2020-07-17 | — | — | CN | claimed |
| US-20170066716-A1 | ENERGETIC N-SUBSTITUTED 3, 3-DINITROAZETIDINE PLASTICIZER AND PREPARATION METHOD THEREOF | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-03-09 | — | — | US | claimed |
| US-9573894-B1 | Energetic N-substituted 3, 3-dinitroazetidine plasticizer and preparation method thereof | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-02-21 | — | — | US | claimed |
| US-20260053963-A1 | RADIOCONJUGATES TARGETING CD33 IN THE TREATMENT OF BREAST CANCER | ACTINIUM PHARMACEUTICALS, INC. | 2026-02-26 | — | — | US | disclosed |
| US-12551584-B1 | Lewis Y radioimmunotherapy for the treatment of cancer | ACTINIUM PHARMACEUTICALS, INC. | 2026-02-17 | — | — | US | disclosed |
| US-5808099-A | ADNAZ, compositions and processes | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1998-09-15 | — | — | US | disclosed |
| WO-1996036602-A1 | ADNAZ, COMPOSITIONS AND PROCESSES | THE UNITED STATES OF AMERICA (US) | 1996-11-21 | — | — | WO | disclosed |